Skip to content
Home
Team
Healthcare
Patient-First Statement
Pipeline
Invest
Investor Hub
Corporate Governance
Shareholder Communications
News
Contact
Menu
Home
Team
Healthcare
Patient-First Statement
Pipeline
Invest
Investor Hub
Corporate Governance
Shareholder Communications
News
Contact
medicinal cannabis
November 27, 2022
Emyria accepted into National Institutes of Health Preclinical Screening Platform for Pain program
November 9, 2022
Why is Ultra-Pure CBD Key to Sustainable Cannabis-based Treatments?
August 17, 2022
Ethics Approval for EMD-RX5 – Clinical Trials Next
August 9, 2022
Step forward in the push for evidence-based CBD treatments
May 25, 2022
EMD-RX5 demonstrates excellent results in Phase 1 study
May 12, 2022
Blog: Bioavailability and its importance to drug development
March 29, 2022
Blog: The Importance of an Over-The-Counter Treatment for Psychological Distress
Search
Search
Search
ASX News
General News
Publications
Thought Leadership
Uncategorised